Multimodal signaling in Boana albopunctata (Anura: Hylidae): reading visual and acoustic cues

Multimodal signaling in Boana albopunctata (Anura: Hylidae): reading visual and acoustic cues. The acoustic mode of communication is important for anurans, but visual communication is beginning to be considered essential for some species, genera, and families. This study focuses on visual and acoustic signals in Boana albopunctata (Hylidae: Cophomantinae) in an attempt to increase our understanding of signaling in this nocturnal Neotropical treefrog. Visual signals were assessed to determine whether they are directed toward conspecific opponents, as has already been observed for some diurnal anurans, or associated with potential morphological asymmetries. Associations between visual and acoustic signals were explored. The results suggest that males may combine visual and acoustic signals (multimodal signaling) synergistically, thereby strengthening the efficiency of information transmission. Thus, in nocturnal anuran species, visual signals may function primarily as an alerting component and multimodal signaling may be a relevant way of communication.Sinalização multimodal em Boana albopunctata (Anura: Hylidae): compreendendo os sinais visuais e acústicos. O modo de comunicação acústico é importante para os anuros, mas a comunicação visual está começando a ser considerada essencial para algumas espécies, gêneros e famílias. Ao investigar sinais visuais e acústicos, o objetivo deste estudo é a melhor compreensão da sinalização em Boana albopunctata (Hylidae: Cophomantinae), uma perereca noturna neotropical. Foi verificado se os sinais visuais são direcionados aos oponentes coespecíficos, como já observado para alguns anuros diurnos, ou se são relacionados a potenciais assimetrias morfológicas. Estudou-se também associações entre sinais visuais e acústicos. Esse estudo leva à compreensão de que os machos podem combinar sinergicamente sinais acústicos e visuais (sinalização multimodal), potencializando assim a eficiência da transmissão de informação. Conclui-se que para espécies noturnas de anuros os sinais visuais podem atuar como componentes de alerta e que a sinalização multimodal pode ser um meio relevante de comunicação

Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction – MiHeart/AMI study

Background: Myocardial infarction remains as a major cause of mortality worldwide and a high rate of survivors develop heart failure as a sequel, resulting in a high morbidity and elevated expenditures for health system resources. We have designed a multicenter trial to test for the efficacy of autologous bone marrow (ABM) mononuclear cell (MC) transplantation in this subgroup of patients. The main hypothesis to be tested is that treated patients will have a significantly higher ejection fraction (EF) improvement after 6 months than controls. Methods: A sample of 300 patients admitted with ST elevation acute myocardial infarction (STEMI) and left ventricle (LV) systolic dysfunction, and submitted to successful mechanical or chemical recanalization of the infarct-related coronary artery will be selected for inclusion and randomized to either treated or control group in a double blind manner. The former group will receive 100 x 106 MC suspended in saline with 5% autologous serum in the culprit vessel, while the latter will receive placebo (saline with 5% autologous serum). Implications: Many phase I/II clinical trials using cell therapy for STEMI have been reported, demonstrating that cell transplantation is safe and may lead to better preserved LV function. Patients with high risk to develop systolic dysfunction have the potential to benefit more. Larger randomized, double blind and controlled trials to test for the efficacy of cell therapies in patients with high risk for developing heart failure are required.Brazilian Ministry of Science and Technology (MCT)/The Financing Agency for Studies and Projects (FINEP

Recommandations sur la gestion du risque et la prise en charge urologique du patient adulte atteint de dysraphisme spinal (spina bifida)

International audienceIntroduction: Improved life expectancy and prenatal screening have changed the demographics of spina bifida (spinal dysraphism) which has presently become a disease of adulthood. Urinary disorders affect almost all patients with spinal dysraphism and are still the leading cause of mortality in these patients. The aim of this work was to establish recommendations for urological management that take into account the specificities of the spina bifida population. Materials and methods: National Diagnosis and Management Guidelines (PNDS) were drafted within the framework of the French Rare Diseases Plan at the initiative of the Centre de Référence Maladies Rares Spina Bifida - Dysraphismes of Rennes University Hospital. It is a collaborative work involving experts from different specialties, mainly urologists and rehabilitation physicians. We conducted a systematic search of the literature in French and English in the various fields covered by these recommendations in the MEDLINE database. In accordance with the methodology recommended by the authorities (Guide_methodologique_pnds.pdf, 2006), proposed recommendations were drafted on the basis of this literature review and then submitted to a review group until a consensus was reached. Results: Bladder dysfunctions induced by spinal dysraphism are multiple and varied and evolve over time. Management must be individually adapted and take into account all the patient's problems, and is therefore necessarily multi-disciplinary. Self-catheterisation is the appropriate micturition method for more than half of the patients and must sometimes be combined with treatments aimed at suppressing any neurogenic detrusor overactivity (NDO) or compliance alteration (anticholinergics, intra-detrusor botulinum toxin). Resort to surgery is sometimes necessary either after failure of non-invasive treatments (e.g. bladder augmentation in case of NDO resistant to pharmacological treatment), or as a first line treatment in the absence of other non-invasive alternatives (e.g. aponeurotic suburethral tape or artificial urinary sphincter for sphincter insufficiency; urinary diversion by ileal conduit if self-catheterisation is impossible). Conclusion: Spinal dysraphism is a complex pathology with multiple neurological, orthopedic, gastrointestinal and urological involvement. The management of bladder and bowel dysfunctions must continue throughout the life of these patients and must be integrated into a multidisciplinary context